Cargando…
Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat
NEW FINDINGS: What is the central question of this study? Urotensin II is upregulated in patients in the later stages of chronic kidney disease (CKD), particularly in individuals requiring dialysis. Could treatment with a urotensin II receptor antagonist slow progression of renal disease? What is th...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492238/ https://www.ncbi.nlm.nih.gov/pubmed/30575177 http://dx.doi.org/10.1113/EP087366 |